BRIEF-Neptune and Ingenutra signs exclusive worldwide agreement for MaxSimil
Oct 7 (Reuters) - Neptune Technologies & Bioressources Inc
* Terms also cover potential collaboration between both companies on clinical trials
* Neptune Technologies & Bioressources Inc says all other terms of agreement remain confidential
* Neptune and Ingenutra sign an exclusive worldwide agreement for Maxsimil
* All other terms of agreement remain confidential.
* Agreement allows neptune to manufacture, distribute and sell Maxsimil in nutraceutical field worldwide
* Says agreement is valid till 2028 Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.